Probable Erythromycin Ototoxicity

Tolman KG Sannella JJ Freston JW , Chemical structure of erythromycin and hepatotoxicity. Ann Intern Med 1974; 81: 58–60.

Mery JP Kanfer A. Ototoxicity of erythromycin in patients with renal insufficiency. N Engl J Med 1979; 301: 944.

van Marion WF van der Meer JWM Kalff MW Schicht SM , Ototoxicity of erythromycin. Lancet 1978; 2: 214–5.

Quinnan GV McCabe WR , Ototoxicity of erythromycin. Lancet 1978; 1: 1160–1.

Karmody CS Weinstein L. Reversible sensorineural hearing loss with intravenous erythromycin lactobionate. Ann Otol Rhinol Laryngol 1977; 86: 9–11.

Eckman MR Johnson T Riess R. Partial deafness after erythromycin. N Engl J Med 1975; 292: 649.

Weinstein L. Antimicrobial agents. In: Goodman LS Gilman A , eds. The pharmacological basis of therapeutics. 5th ed. New York: Macmillan, 1975: 1226.

Mintz U Amir J Pinkhas J de Vries A. Transient perceptive deafness due to erythromycin lactobionate. JAMA 1973; 225: 1122–3.

Weinstein L. Antimicrobial agents, general considerations. In: Goodman LS Gilman A , eds. The pharmacological basis of therapeutics. 5th ed. New York: Macmillan, 1975: 1108.

Anderson RJ Gambertoglio JG Schrier RW , Clinical use of drugs in renal failure. Springfield, IL: Charles Thomas, 1976.

Black RE Lau WK Weinstein RJ Young LS Hewitt WL , Ototoxicity of amikacin. Antimicrob Agents Chemother 1976; 9: 956–61.

Lerner SA Seligsohn R Matz GJ , Comparative clinical studies of ototoxicity and nephrotoxicity of amikacin and genta-micin. Am J Med 1977; 62: 919–23.

Sarubbi FA Hull JH , Amikacin serum concentrations: Prediction of levels and dosage guidelines. Ann Intern Med 1978: 89: 612–8.

Wagner JG , Fundamentals of clinical pharmacokinetics. Hamilton, IL: Drug Intelligence, 1975.

Regeur L Colding H Jensen H Kampmann JP , Pharmacokinetics of amikacin during hemodialysis and peritoneal dialysis. Antimicrob Agents Chemother 1977; 11: 214–8.

Lane AZ Wright HE Blair RC , Ototoxicity and nephrotoxicity of amikacin. Am J Med 1977; 62: 911–8.